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1. Introduction 
The increase in longevity achieved at present, the population has determined a striking 
increase in the prevalence of certain diseases and in other cases, the emergence of new forms 
of illness and during different life stages (1). 
Osteoporosis is defined as a decrease in bone mass associated with the deterioration of bone 
tissue architecture and increased fracture risk, has become a serious public health problem 
in our society that affects a wide strata of the population age variable, though increasingly 
common among younger (2). There are two types of osteoporosis, primary and secondary. 
Primary osteoporosis is rare affecting one case per 100,000 subjects. For high school, its 
frequency is higher, being secondary to diseases or drug therapies. Table 1 shows the main 
causes that can lead to a primary or secondary osteoporosis. 
The bone will undergo changes during growth reaching its peak during the second decade. 
After the fourth decade, there is progressive increase in bone loss that mainly affects 
trabecular tissue at both the peripheral and axial. Accordingly, it is during childhood when 
determining events occur in the development of adequate bone mineralization and bone 
mass final (3).  
It is now accepted that osteoporosis in the adult subject has its origins in childhood. 
Accordingly, the prevention of it would begin with the empowerment of those factors that 
promote the acquisition of optimal bone mass development. Now if we take into account the 
dietary habits and sedentary marking between the current youth population, we can 
glimpse the high risk of developing the disorder to an increasingly early age (3).  
During the first decade of life, the appendicular skeleton is growing faster than the axial. 
Also, the bone mineralization process starts in utero found strongly influenced by calcium 
intake during growth. However, calcium requirements vary throughout life, being greatest 
during the first years of life and in times such as puberty, pregnancy and lactation. 
Moreover, the loss of bone mass increases with age and accelerates with menopause. In this 
sense, it is advisable to increase the intake of calcium from the perimenopause.  
For pediatric patients, there is a relationship between bone mass and size. However, in 
periods like puberty and after the pubertal growth spurt can be established called an 
imbalance between the rate of bone growth rate and increased bone mass resulting from this 
transient increase in bone fragility (4). 
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Primary Osteoporosis 
Idiopathic juvenile osteoporosis Marfan syndrome 
Osteogenesis imperfecta Homocystinuria 
Ehler Danlos syndrome  
Bruck syndrome  
Secundary Osteoporosis 
Neuromuscular Disease Procesos Crónicos 
Cerebral Palsy Leucemia 
Duchenne Muscular Dystrophy Fibrosis Quística 
Prolonged Immobilization Malabsorción intestinal  
Endocrine Diseases Talasemia 
Hypogonadism Cirrosis Biliar Primaria 
Turner Syndrome Nefropatías 
Growth hormone deficiency Anorexia Nerviosa 
Hyperthyroidism 
hyperprolactinemia 
Trasplantes  
Infección por VIH 
Cushing Syndrome 
Congenital Metabolic Disorders 
Yatrogenia 
Corticosteroids 
Gaucher Disease 
 
Metotrexate 
Cyclosporine 
Heparin 
Anticonvulsivants 
Radiotherapy 
Table 1. Causes of primary and secondary osteoporosis in children 
On the other hand, it is normal that there is a correlation between the stage of pubertal 
development and BMD at both the peripheral and axial. Among girls after menarche has 
been a significant increase in BMD. BMD in boys increases after puberty, with a more 
extended in time because their pubertal development is slower (5). 
Genetic factors in turn, are equally important in the development of an adequate peak bone 
mass. Thus, a correlation in BMD between twins. For their part, black women have greater 
BMD and thus a lower incidence of osteoporosis when compared to white women. Also 
found lower BMD among women whose mothers had a post-menopausal status with 
osteoporosis compared to those other women the same age but without such a history. 
Accordingly, it should raise the transmission of genetic information is carried out mainly 
through the mother (6). 
Analyzing the etiology of osteoporosis in children are significantly different from those in 
adulthood. Accordingly, the diagnostic approach would be completely different in children 
compared to adults. Among the risk factors associated with the occurrence of bone 
metabolism during childhood are processes that interfere with proper bone mineralization, 
the absence of positive stimulus of calcium and vitamin D from diet or exercise to obtain 
adequate bone mass. Other causes are disorders that cause interference in pubertal 
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development as well as any conditions that cause increased bone loss. Finally, prolonged 
exposure to certain drugs that induce the development of osteoporosis.  
Given the above should be considered the early diagnosis of osteoporosis in pediatric 
patients who have had one or more fractures are not preceded by trauma or as a result of 
minor trauma. Moreover, the development of significant angular deformities in the 
extremities and the presence of a marked kyphosis should guide the clinician to the 
presence of impaired bone quality. 
This review aims to provide guidance on the characteristics of the process of normal and 
abnormal bone mineralization in the pediatric patient, the main factors involved and the 
existing prevention strategies. 
2. Bone mass concept and assessment of their status 
Bone mass is defined as the total amount of bone tissue in the organism including the 
extracellular matrix ossified. At present, it is accepted that the acquisition of appropriate 
peak bone mass is essential to prevent osteoporosis later in life. Since this formation and 
accumulation of bone mass occurs during the first decades of life, control of bone 
mineralization during childhood is a significant aspect to assess interest. This monitoring 
should aim to identify children at risk of developing osteopenia. Also, in the general 
population should implement measures to prevent the onset of the disease promoting 
lifestyles and measures to increase bone mass (7). 
The development of an adequate level of bone mass is partly dependent on nutritional factors, 
so it is necessary to maintain an adequate nutrient supply during the growing season. Another 
aspect to consider genetic factors, accounting for 60% of total factors. In adulthood decreases 
the neo-bone formation after a period in which bone mass remains stable (8).  
Puberty brings the largest increase in bone mineral density in both sexes, however, as in any 
period may generate changes to diet and exercise as much as 20% (9). Bone mass is 
increased from birth to be reduced by calcium deposition significantly as we approach the 
third decade or so. To three years increases to 30% after 20% and reach puberty about 40%. 
From the end of growth and to reach adulthood is increasing by 15%. Even 10 years ago 
mineralization at the same rate in both sexes. From this age is accelerated significantly in the 
girls (10). 
The diagnosis and even prevention evaluation and therapy of osteoporosis may be 
jeopardized in a special way in the child all because of the need to use techniques which, 
although sensitive, reproducible and precise, resulting quick, painless, safe and non 
invasive. 
Of all the methods proposed by the National Osteoporosis Foundation to assess the quality 
of bone, the most used technique is dual x-ray absorptiometry (DEXA). The basis of this 
technique in the study of attenuation is subjected to a dual X-ray beam through bone tissue 
(11). Although it can be done at different levels, the benchmarks for determining the criteria 
of normality, osteopenia or osteoporosis referred to data obtained at the height of the 
femoral neck or lumbar vertebrae (L2-L4) of the reference population. The interpretation of 
this technique has some difficulties in the child (12). There are already benchmarks (13-15), 
although obtained in cross-sectional studies. 
The measures are available in axial regions (hip, spine) or peripheral (calcaneus, tibia, knee, 
radio and phalanges), but it has shown that measurements in predicting spinal fracture risk 
at that level, but not others, and so does the rest of the locations where BMD is measured.  
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In children, the area selection is further complicated because the timing and rate of 
mineralization depends on the biological age (13). Should be selected sufficiently 
vascularized bone, with good motility and under some pressure. In this regard, the 
determination in the calcaneus could induce excessive bias to withstand pressure, although 
some authors is the preferred (14).  
Other recent application techniques are ultrasound imaging and computed tomography. It 
is noninvasive, excellent acceptance of any age which have been effective as bone 
assessment procedures in both the adult and the child (15). However, in the case of 
computed tomography to excessive cost limits their use as a technique for the prevention of 
osteoporosis. 
3. Bone mineralization process 
Bone mineralization is a complex process regulated by both genetic and hormonal factors, 
environmental and nutritional (16). From a genetic standpoint, the mineralization is 
controlled by a large group of genes. Among the most studied is the gene that controls 
vitamin D receptor, which depends on calcium absorption in the intestine. 
Hormonal level, there are several hormones involved in bone mineralization. These include 
parathyroid hormone which balances the mechanisms of formation and resorption of bone 
at the same time enhances the action of vitamin D. Calcitonin, which inhibits the action of 
osteoclasts, and growth hormone, HGH and IGF-1 that acts in the formation of cartilage and 
promotes the synthesis of the active metabolite of vitamin D (17). 
Other molecules with activity on bone mass are the corticosteroids. They only act on bone 
mineralization when increased above normal levels, decreasing bone mass and bone 
growth. This is an important consideration in those children treated with corticosteroids. 
Thyroid hormones, in turn, are also involved in mineralization diminishing with increasing 
concentration. But all of these factors may also act on the environmental factors that can 
intervene by modifying diet and lifestyle (18). 
4. Concept of osteopenia and osteoporosis 
Osteopenia is defined by decreased bone mineral density between -1 and -2.5 SD for age, 
sex, height and pubertal stage. In cases where the decrease in bone mineral density is below 
2 SD is considered osteoporosis (19). 
Osteoporosis was defined in 1991 as a systemic skeletal disease characterized by low bone 
mass and microarchitectural deterioration of bone tissue, which leads to increased bone 
fragility with a consequent increase in fracture risk. This definition implies a qualitative 
concept of altered bone architecture and a quantity related to bone density (20). Both 
osteoporosis and osteopenia may be primary as in aging or menopause but may also result 
from inadequate nutrition, and hormonal disorders or diseases of the bone. 
However, there are childhood diseases that may present with osteopenia thereby increasing 
the risk of osteoporosis in adulthood. Among the mechanisms of production of osteopenia 
could cite many, though, could be divided into three main groups. Those processes that 
occur with an inadequate intake of nutrients such as anorexia nervosa, bulimia, protein-
calorie malnutrition or poorly controlled diets (21). A second group would be composed of 
those disorders with intestinal malabsorption boxes. Within this section as possible 
symptoms of osteopenia generators could include celiac disease, cystic fibrosis, intolerance 
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to cow's milk proteins and inflammatory bowel disease. Other processes potentially 
involved in the development of osteopenia will neuropathy and liver disease that present 
with an impairment of the synthesis of active metabolites of vitamin D. Other processes 
involved will be the states of metabolic acidosis, prolonged administration of certain drugs 
such as anticonvulsants or corticosteroids and pictures of hypogonadism (22). 
5. Nutritional factors 
Proper nutrition is a key factor in maintaining adequate skeletal mineralization. In this 
process of bone mineralization energy and nutrients intervene in various ways, either by 
encouraging the development of cell mitosis, participating as visual elements, to be a source 
of vitamins which will involve regulating the synthesis of bone matrix and promoting the 
absorption level intestinal calcium or contributing to the synthesis of various hormones and 
factors crecimiento (23). 
By feeding the body receives visual elements, vitamins intervene by regulating the synthesis 
of bone matrix and intestinal absorption of calcium and other minerals whose primary 
function is to act in the formation and consolidation of mineralized bone. Another essential 
aspect of bone remodeling in the child will be energy intake. This is an essential as the 
volume decreases in energy intake induce delays in growth, maturation and hence bone 
mineralization (24). Then in children with malnutrition by default is necessary to control the 
state of bone mineralization. 
The bone mineralization process will necessarily regulated by protein intake through the 
diet. Its role essentially plastic makes these elements are essential for the synthesis of bone 
matrix. In this sense, the child, situations of inadequate intake may induce default to the 
emergence of problems of mineralization. On the contrary, when its contribution in the diet 
is excessive can cause hypercalciuria boxes, this is due to increased excretion of acid 
produced during protein catabolism. At present it is possible that the protein diet consumed 
in most developed countries it is closely linked with the increase in osteoporosis in the 
population (25). 
Another aspect to consider is the ratio of sodium ingested with the level of calcium excretion 
by the kidney. Sodium and calcium share the same carrier at the proximal renal tubule. 
Although and yet there is no need to adjust the contribution of calcium to sodium intake 
through the diet in children (26). Calcium is an essential pillar in the prevention of 
osteoporosis. In our body and especially in the bones is deposited as hydroxyapatite 
crystals. Your deposit varies throughout life from 30 grams at birth to about 1.300 grams in 
adulthood (27). 
Given the above will be necessary to modulate calcium intake during periods of increased 
growth and, especially during adolescence. During adolescence tends to accumulate 40% of 
total bone mass produced throughout life. Several studies have shown that calcium 
supplementation during adolescence increases bone mineral density (28). After 
administering 500 ml of milk per day during childhood will ensure intake of about 400mg of 
calcium, equivalent to 60% of the recommended daily amount. 
Moreover, we have to take into account the bioavailability of calcium in food. The presence 
of phytates inhibit absorption and therefore vegetables, legumes and cereals despite 
containing high levels of calcium, it is not as comparable as that of milk. Similarly oxalates, 
alcohol, caffeine and phosphates hinder calcium absorption even when present in the diet 
(29, 30). Finally, pictures of obesity and overweight in children have been associated with 
www.intechopen.com
 
Osteoporosis 
 
374 
increased bone density. However there is evidence linking these situations with a higher 
incidence of fractures (31). 
Vitamin D is another factor regulating the homeostasis calcium / phosphorus. Its main 
sources are dairy products. Exposure to sunlight or UV light promotes the metabolism of it. 
However, alterations in intestinal absorption mechanism and factors affecting their 
metabolism at the level of the skin should be considered as processes that alter bone 
formation and thus risk factors for developing osteoporosis (32). 
6. Idiopathic juvenile osteoporosis 
In some pediatric patients (usually young) are not able to establish any risk factors for 
osteoporosis. In these cases must be considered the possibility of presenting idiopathic 
juvenile osteoporosis. Its etiology is unknown, manifesting itself in some cases for an 
accidental radiological finding which may also require a significant osteopenia, short stature 
and kyphosis (secondary to vertebral crush fractures) (32). Generally do not exhibit any 
endocrine abnormality nor metabolism of calcium/ phosphorus. The levels of vitamin D 
and calcitonin are variable in these patients. For bone biopsy, this is not conclusive proof but 
often shows an increase of osteocytes in trabecular bone as well as signs of increased bone 
resorption. In general, treatment consists of substitution of calcium and calcitriol, tending to 
improve spontaneously in the post pubertal period by several authors due to the effect of 
gonadal hormones (33). 
7. Osteogenesis imperfecta 
Osteogenesis imperfecta is a genetic disease, autosomal dominant, in which there is an 
abnormality in the formation of collagen type 1 (34). This disorder causes weakness and 
bone fragility of varying degrees of severity and subsequent pathological fractures, as well 
as affecting other tissues. The etiology of this disease lies in the mutation of genes that 
encode both qualitative and quantitative production of collagen fibers. In terms of 
prevalence in the world, this ranges from about 1 case per 30,000 live births (34). The 
continuous advances in diagnosis have created new expectations for subjects with the 
disease, greatly improving their quality of life. At present there is no effective treatment, 
healing, since it can not act directly on the formation of collagen type I (34). Throughout 
history have used various medical treatments (calcitonin, anabolic steroids, etc.) to try to 
increase bone mass, to no avail. Currently, treatment is symptomatic and should be 
approached in a multidisciplinary manner. The best results were achieved with growth 
hormone (GH) and bisphosphonates (34). 
8. Osteopathy associated with use of drugs 
Another group of pediatric patients at high risk for osteoporosis are those subjects taking 
medications which interfere with the normal process of bone mineralization. The drugs 
most commonly associated with the development of bone disease or iatrogenic 
demineralizantes include steroids, anticonvulsants, cyclosporine, anthracyclines, 
methotrexate, warfarin and agonists of gonadotropin-releasing hormone (35). 
In the case of steroids, these lead to the development of osteoporosis secondary to increased 
bone resorption. In addition, they inhibit intestinal absorption of calcium, decreased tubular 
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reabsorption of calcium and induce a secondary hyperparathyroidism. They also inhibit 
pituitary gonadotropin secretion and decrease the response of estrogen/testosterone to the 
follicle stimulating hormone (FSH). A level of osteoblasts caused a decrease in their ability 
to replicate, in turn stimulating the expression of collagenase by the osteoblast and thereby 
inducing the increase in bone matrix degradation with a decrease in the synthesis of growth 
factors (IGF1, IGF-2) (36). 
Appropriate strategies to prevent osteoporosis from childhood: The prevention of 
osteoporosis to necessarily an assessment of bone mineralization status since early infancy, 
particularly in subjects at risk. In this sense, preterm infants, patients with malabsorption 
syndromes and corticosteroid therapy patients constitute the population most at risk of poor 
bone mineralization (37, 38). 
The bioavailability of calcium in milk is far superior to commercial formulas, making it the 
leading source for calcium during breastfeeding. Only in the case of infants it should 
increase their calcium intake to the recommended supplementary with commercial formulas 
that have a higher calcium content (39). 
In children aged 1 to 8 years there is no explicit consensus on the specific requirements of 
calcium. In any case, we recommend an intake of 500 mg per day for ages 1 and 3 years (40). 
This figure should be increased as they age and approach puberty. Thus, for ages 4 to 8 
years the requirements will amount up to 800mg calcium per day. But have found no overt 
health benefits by increasing the daily amount (41). And at puberty, it is estimated that for 
every inch of growth are required calcio 20g (41). 
Given the above, eating disorders, inflammatory bowel disease or the use of corticosteroids 
and prolonged rest in the minors are situations that require an attitude of monitoring and 
supervision by health staff (41). 
It is estimated that the highest positive balance is achieved with an average daily intake of 
1300mg. By contrast, those exposed to lower levels will have a negative impact on bone 
mineralization process (42). This corresponds to measurements made on white teens. In the 
case of blacks and adolescents have shown a better efficiency for the absorption of dietary 
calcium, can reach the same peak bone mass even with lower contributions of calcium (43). 
Excess calcium in the diet, in turn, can cause a deficiency of iron and zinc, while favoring the 
formation of kidney stones (44). Similarly as phosphates present in carbonated drinks can 
also act by inhibiting the absorption of calcium in the intestine (45).  
In cases of subjects with lactose intolerance, the simple addition of commercial lactase or 
ingestion of fermented dairy products like yogurt can remedy this situation (46).  
The existence of toxic habits such as snuff or alcohol consumption can also interfere with the 
process of bone mineralization (47). But if there is a successful strategy to prevent 
osteoporosis from childhood this is the regular practice of exercise (48). The physical 
exercise from an early age not only ensure optimal weight status but also a formidable 
mineralization of our skeleton, reason is of great importance when the subject population 
are children and adolescents (49, 50). The continued practice of physical activity helps to 
acquire peak bone mass genetically determined (51). Although, to achieve these benefits, the 
current recommendations set out the need to practice a minimum of three days a week (52). 
Moreover, at present it is unknown whether calcium intake through diet may or may not 
alter the beneficial effect of exercise (52). 
With regard to drug-induced osteoporosis, the most important preventive factor is the wise 
use and dosage of the same (53).  
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In summary, we conclude that the onset osteoporosis in children differs in its clinical 
management of osteoporosis in adults. In this sense, the early identification of risk grpos be 
a priority. Therefore it should be emphasized that during the first and second decade of life, 
events occur which are essential for the proper development of bone metabolism. On this 
basis, the prevention of osteoporosis in adults should begin as early as the early childhood.  
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